Highlights and Quick Summary
- Debt/Equity for the quarter ending February 28, 2023 was 0.0 (a 0.0% decrease compared to previous quarter)
- Year-over-year quarterly Debt/Equity decreased by -20.0%
- Annual Debt/Equity for 2022 was 0.0 (a -16.67% decrease from previous year)
- Annual Debt/Equity for 2021 was 0.0 (a -99.84% decrease from previous year)
- Annual Debt/Equity for 2020 was 0.38 (a 153.83% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Equity of Organigram Holdings Inc.
Most recent Debt/Equityof OGI including historical data for past 10 years.Interactive Chart of Debt/Equity of Organigram Holdings Inc.
Organigram Holdings Inc. Debt/Equity for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | 0.0 | – | – | – | – |
2022 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
2021 | 0.0 | 0.0 | 0.0 | 0.22 | 0.0 |
2020 | 0.36 | 0.38 | 0.27 | 0.23 | 0.38 |
2019 | 0.26 | 0.15 | 0.15 | 0.22 | 0.15 |
2018 | – | – | 0.42 | 0.54 | 0.54 |
2017 | – | – | – | – | 0.04 |
2016 | – | – | – | – | 0.17 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic